Compare OGI & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGI | FLC |
|---|---|---|
| Founded | 2013 | N/A |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.3M | 162.4M |
| IPO Year | 2015 | 2003 |
| Metric | OGI | FLC |
|---|---|---|
| Price | $0.93 | $15.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.39 | N/A |
| AVG Volume (30 Days) | ★ 447.7K | 41.4K |
| Earning Date | 08-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.95 | N/A |
| Revenue Next Year | $30.97 | N/A |
| P/E Ratio | $13.91 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $15.33 |
| 52 Week High | $2.24 | $18.09 |
| Indicator | OGI | FLC |
|---|---|---|
| Relative Strength Index (RSI) | 34.74 | 44.70 |
| Support Level | $0.92 | $15.33 |
| Resistance Level | $1.07 | $15.85 |
| Average True Range (ATR) | 0.04 | 0.21 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 15.67 | 61.54 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.